These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 12843219

  • 1. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T, Kanno T, Futatsubashi M, Okada H, Yoshikawa E, Nakamura F, Takekuma M, Maeda M, Ouchi Y.
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [Abstract] [Full Text] [Related]

  • 2. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T, Nobezawa S, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, Takekuma M, Maeda M, Ouchi Y.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [Abstract] [Full Text] [Related]

  • 3. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M, Choi HS, Yoo E, Bong JK, Ryu YH, Lee JD.
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [Abstract] [Full Text] [Related]

  • 4. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
    de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W.
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1283-8. PubMed ID: 12271408
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
    Yen TC, See LC, Lai CH, Yah-Huei CW, Ng KK, Ma SY, Lin WJ, Chen JT, Chen WJ, Lai CR, Hsueh S.
    J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
    Khan N, Oriuchi N, Zhang H, Higuchi T, Tian M, Inoue T, Sato N, Endo K.
    Nucl Med Commun; 2003 Apr; 24(4):359-66. PubMed ID: 12673163
    [Abstract] [Full Text] [Related]

  • 7. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
    Pieterman RM, Que TH, Elsinga PH, Pruim J, van Putten JW, Willemsen AT, Vaalburg W, Groen HJ.
    J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
    [Abstract] [Full Text] [Related]

  • 8. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D.
    J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.
    Koyama K, Okamura T, Kawabe J, Ozawa N, Torii K, Umesaki N, Miyama M, Ochi H, Yamada R.
    J Nucl Med; 2003 Mar; 44(3):353-8. PubMed ID: 12621000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD.
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY.
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [Abstract] [Full Text] [Related]

  • 15. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
    Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH.
    J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
    [Abstract] [Full Text] [Related]

  • 16. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R, Lemaire C, Jerusalem G, Moreau P, Cataldo D, Duysinx B, Aerts J, Fassotte MF, Foidart J, Luxen A.
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Cobben DC, van der Laan BF, Maas B, Vaalburg W, Suurmeijer AJ, Hoekstra HJ, Jager PL, Elsinga PH.
    J Nucl Med; 2004 Feb; 45(2):226-31. PubMed ID: 14960640
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
    Drieskens O, Stroobants S, Gysen M, Vandenbosch G, Mortelmans L, Vergote I.
    Gynecol Obstet Invest; 2003 Feb; 55(3):130-4. PubMed ID: 12865590
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.